Health outcomes of pediatric rheumatic diseases

Best Practice and Research: Clinical Rheumatology

Volumn 28, Issue 2, 2014, Pages 331-350

  Luca, Nadia J C ^a   Feldman, Brian M ^b,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Consensus development; Criteria; Juvenile dermatomyositis; Juvenile idiopathic arthritis; Juvenile systemic lupus erythematosus; Outcome assessment

Indexed keywords

ARTICLE; CONSENSUS; DISEASE ACTIVITY; HEALTH STATUS; JUVENILE DERMATOMYOSITIS; JUVENILE RHEUMATOID ARTHRITIS; JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS; OUTCOME ASSESSMENT; PERCEPTION; PRIORITY JOURNAL; QUALITY OF LIFE; RELIABILITY; SYSTEMIC LUPUS ERYTHEMATOSUS; VALIDITY;

CONSENSUS DEVELOPMENT; CRITERIA; JUVENILE DERMATOMYOSITIS; JUVENILE IDIOPATHIC ARTHRITIS; JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS; OUTCOME ASSESSMENT;

ARTHRITIS, JUVENILE; CHILD; DERMATOMYOSITIS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; OUTCOME ASSESSMENT (HEALTH CARE); PEDIATRICS; QUALITY OF LIFE; RHEUMATIC DISEASES; RHEUMATOLOGY;

EID: 84903272336     PISSN: 15216942     EISSN: 15321770     Source Type: Journal    
DOI: 10.1016/j.berh.2014.04.001     Document Type: Review

References (105)

1. W. Thomson Electrical units of measurement Popular Lectures 1 1883
2. N. Ruperto, A. Pistorio, and A. Ravelli et al. Criteria to define response to therapy in paediatric rheumatic diseases Eur J Clin Pharmacol 67 Suppl. 1 2010 125 131
3. G. Filocamo, A. Consolaro, and B. Schiappapietra et al. A new approach to clinical care of juvenile idiopathic arthritis: the Juvenile Arthritis Multidimensional Assessment Report J Rheumatol 38 2011 938 953
4. E.M. Dewitt Outcomes research in childhood autoimmune diseases Rheum Dis Clin North Am 39 2013 921 933
5. D.L. Patrick, G. Guyatt, and C. Acquadro Chapter 17: patient-reported outcomes 2008 John Wiley & Sons, Ltd London, UK
6. Organization WH Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference 1948
7. J. Bircher Towards a dynamic definition of health and disease Med Health Care Philos 8 2005 335 341
8. Organization WH Towards a common language for functioning, disability and health: the International Classification of Functioning, Disability and Health. ICF beginner's guide Geneva 2002
9. M. Arkela-Kautiainen, J. Haapasaari, and H. Kautiainen et al. Functioning and preferences for improvement of health among patients with juvenile idiopathic arthritis in early adulthood using the WHO ICF model J Rheumatol 33 2006 1369 1376
10. D.P. Symmons Disease assessment indices: activity, damage and severity Bailliere's Clin Rheumatol 9 1995 267 285
11. G. Valentini, A.J. Silman, and D. Veale Assessment of disease activity Clin Exp Rheumatol 21 2003 S39 S41
12. T.A. Medsger Jr., S. Bombardieri, and L. Czirjak et al. Assessment of disease severity and prognosis Clin Exp Rheumatol 21 2003 S42 S46
13. M. Calvert, J. Blazeby, and D.G. Altman et al. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension JAMA 309 2013 814 822
14. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization Soc Sci Med 41 1995 1403 1409
15. G.W. Gong, N.L. Young, and H. Dempster et al. The quality of My Life questionnaire: the minimal clinically important difference for pediatric rheumatology patients J Rheumatol 34 2007 581 587
16. H. de Vet, C.B. Terwee, and L.B. Mokkink et al. Measurement in medicine: a practical guide 2011 Cambridge University Press Cambridge, UK
17. J.A. Singh, D.H. Solomon, and M. Dougados et al. Development of classification and response criteria for rheumatic diseases Arthritis Rheum 55 2006 348 352
18. H.I. Brunner, and A. Ravelli Developing outcome measures for paediatric rheumatic diseases Best Pract Res Clin Rheumatol 23 2009 609 624
19. B. Kirshner, and G. Guyatt A methodological framework for assessing health indices J Chronic Dis 38 1985 27 36
20. C.A. Wallace, N. Ruperto, and E. Giannini Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis J Rheumatol 31 2004 2290 2294
21. A.M. Huber, B.M. Feldman, and R.M. Rennebohm et al. Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies Arthritis Rheum 50 2004 1595 1603
22. G.H. Guyatt, C. Bombardier, and P.X. Tugwell Measuring disease-specific quality of life in clinical trials CMAJ 134 1986 889 895
23. M. Batthish, R. Schneider, and A.V. Ramanan et al. What does "active disease" mean? patient and parent perceptions of disease activity in the systemic arthritis form of juvenile idiopathic arthritis (SO-JIA) Rheumatology 44 2005 796 799
24. N. Ruperto, S. Meiorin, and S.M. Iusan et al. Consensus procedures and their role in pediatric rheumatology Curr Rheumatol Rep 10 2008 142 146
25. D.T. Felson, and J.J. Anderson Methodological and statistical approaches to criteria development in rheumatic diseases Bailliere's Clin Rheumatol 9 1995 253 266
26. D.L. Streiner, and G.R. Norman Chapter 18. Principal components and factor analysis: fooling around with factors Health measurement scales: a practical guide to their development and use 2003 Oxford University Press
27. J. Jones, and D. Hunter Consensus methods for medical and health services research BMJ 311 1995 376 380
28. R. Nair, R. Aggarwal, and D. Khanna Methods of formal consensus in classification/diagnostic criteria and guideline development Semin Arthritis Rheum 41 2011 95 105
29. E.H. Giannini, N. Ruperto, and A. Ravelli et al. Preliminary definition of improvement in juvenile arthritis Arthritis Rheum 40 1997 1202 1209
30. N. Ruperto, A. Ravelli, and K.J. Murray et al. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis Rheumatology 42 2003 1452 1459
31. S.R. Johnson, O.N. Goek, and D. Singh-Grewal et al. Classification criteria in rheumatic diseases: a review of methodologic properties Arthritis Rheum 57 2007 1119 1133
32. H.I. Brunner, D.J. Lovell, and B.K. Finck et al. Preliminary definition of disease flare in juvenile rheumatoid arthritis J Rheumatol 29 2002 1058 1064
33. S. Magni-Manzoni, N. Ruperto, and A. Pistorio et al. Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis Arthritis Rheum 59 2008 1120 1127
34. L.B. Mokkink, C.B. Terwee, and D.L. Patrick et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes J Clin Epidemiol 63 2010 737 745
35. M. Dougados, and L. Gossec Classification criteria for rheumatic diseases: why and how? Arthritis Rheum 57 2007 1112 1115
36. N. Ruperto, A. Ravelli, and F. Falcini et al. Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate. Italian Pediatric Rheumatology Study Group Ann Rheum Dis 57 1998 38 41
37. A. Consolaro, N. Ruperto, and A. Bazso et al. Development and validation of a composite disease activity score for juvenile idiopathic arthritis Arthritis Rheum 61 2009 658 666
38. S. Ringold, R. Bittner, and T. Neogi et al. Performance of rheumatoid arthritis disease activity measures and juvenile arthritis disease activity scores in polyarticular-course juvenile idiopathic arthritis: analysis of their ability to classify the American College of Rheumatology pediatric measures of response and the preliminary criteria for flare and inactive disease Arthritis Care Res (Hoboken) 62 2010 1095 1102
39. M. Bulatovic Calasan, L.D. de Vries, and S.J. Vastert et al. Interpretation of the juvenile arthritis disease activity score: responsiveness, clinically important difference and levels of disease activity in prospective cohorts of patients with juvenile idiopathic arthritis Rheumatology (Oxford, England) 53 2 2014 307 312
40. F. McErlane, M.W. Beresford, and E.M. Baildam et al. Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis 72 12 2013 1983 1988
41. C.A. Wallace, A. Ravelli, and B. Huang et al. Preliminary validation of clinical remission criteria using the OMERACT filter for select categories of juvenile idiopathic arthritis J Rheumatol 33 2006 789 795
42. A.V. Ramanan, R. Schneider, and M. Batthish et al. Developing a disease activity tool for systemic-onset juvenile idiopathic arthritis by international consensus using the Delphi approach Rheumatology 44 2005 1574 1578
43. S. Ishikawa, M. Shimizu, and K. Ueno et al. Soluble ST2 as a marker of disease activity in systemic juvenile idiopathic arthritis Cytokine 62 2013 272 277
44. D. Holzinger, M. Frosch, and A. Kastrup et al. The toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis Ann Rheum Dis 71 2012 974 980
45. M.T. Rahman, A. Myles, and P. Gaur et al. TLR4 endogenous ligand MRP8/14 level in enthesitis-related arthritis and its association with disease activity and TLR4 expression Rheumatology (Oxford) 53 2014 270 274
46. H. Moncrieffe, S. Ursu, and D. Holzinger et al. A subgroup of juvenile idiopathic arthritis patients who respond well to methotrexate are identified by the serum biomarker MRP8/14 protein Rheumatology (Oxford) 52 2013 1467 1476
47. J. Gerss, J. Roth, and D. Holzinger et al. Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study Ann Rheum Dis 71 2012 1991 1997
48. P.J. Hunter, K. Nistala, and N. Jina et al. Biologic predictors of extension of oligoarticular juvenile idiopathic arthritis as determined from synovial fluid cellular composition and gene expression Arthritis Rheum 62 2010 896 907
49. N. Ruperto, A. Ravelli, and S. Oliveira et al. The Pediatric Rheumatology International Trials Organization/American College of Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the definition of improvement Arthritis Rheum 55 2006 355 363
50. N. Ruperto, A. Pistorio, and A. Ravelli et al. The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis Arthritis Care Res (Hoboken) 62 2010 1533 1541
51. L.G. Rider, E.H. Giannini, and M. Harris-Love et al. Defining clinical improvement in adult and juvenile myositis J Rheumatol 30 2003 603 617
52. C. Bombardier, D.D. Gladman, and M.B. Urowitz et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE Arthritis Rheum 35 1992 630 640
53. E.M. Hay, P.A. Bacon, and C. Gordon et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus Q J Med 86 1993 447 458
54. M.H. Liang, S.A. Socher, and M.G. Larson et al. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus Arthritis Rheum 32 1989 1107 1118
55. C. Vitali, W. Bencivelli, and D.A. Isenberg et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE Clin Exp Rheumatol 10 1992 541 547
56. H.I. Brunner, B.M. Feldman, and C. Bombardier et al. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus Arthritis Rheum 42 1999 1354 1360
57. H.I. Brunner, E.D. Silverman, and C. Bombardier et al. European Consensus Lupus Activity Measurement is sensitive to change in disease activity in childhood-onset systemic lupus erythematosus Arthritis Rheum 49 2003 335 341
58. R. Mina, M.S. Klein-Gitelman, and A. Ravelli et al. Inactive disease and remission in childhood-onset systemic lupus erythematosus Arthritis Care Res (Hoboken) 64 2012 683 693
59. L.G. Rider, V.P. Werth, and A.M. Huber et al. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI) Arthritis Care Res (Hoboken) 63 Suppl. 11 2011 S118 S157
60. L.G. Rider, D. Koziol, and E.H. Giannini et al. Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies Arthritis Care Res (Hoboken) 62 2010 465 472
61. N. Ruperto, A. Ravelli, and A. Pistorio et al. The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study Arthritis Rheum 59 2008 4 13
62. R.K. Bode, M.S. Klein-Gitelman, and M.L. Miller et al. Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence Arthritis Rheum 49 2003 7 15
63. S.M. Sultan, E. Allen, and C.V. Oddis et al. Reliability and validity of the myositis disease activity assessment tool Arthritis Rheum 58 2008 3593 3599
64. A.M. Huber, E.M. Dugan, and P.A. Lachenbruch et al. The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathy Rheumatology 46 2007 1606 1611
65. D. Lazarevic, A. Pistorio, and E. Palmisani et al. The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis 72 5 2013 686 693
66. N.J. Luca, and B.M. Feldman Paediatric rheumatic disease: defining clinically inactive disease in juvenile dermatomyositis Nat Rev Rheumatol 8 2012 638 639
67. S. Viola, E. Felici, and S. Magni-Manzoni et al. Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis Arthritis Rheum 52 2005 2092 2102
68. G.Z. Susic, R.M. Stojanovic, and N.N. Pejnovic et al. Analysis of disease activity, functional disability and articular damage in patients with juvenile idiopathic arthritis: a prospective outcome study Clin Exp Rheumatol 29 2011 337 344
69. B. Lattanzi, A. Consolaro, and N. Solari et al. Measures of disease activity and damage in pediatric systemic lupus erythematosus: British Isles Lupus Assessment Group (BILAG), European Consensus Lupus Activity Measurement (ECLAM), Systemic Lupus Activity Measure (SLAM), Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), Physician's Global Assessment of Disease Activity (MD Global), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SLICC/ACR DI; SDI) Arthritis Care Res (Hoboken) 63 Suppl. 11 2011 S112 S117
70. R. Gutierrez-Suarez, N. Ruperto, and R. Gastaldi et al. A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index based on the analysis of 1,015 patients with juvenile-onset systemic lupus erythematosus Arthritis Rheum 54 2006 2989 2996
71. L.G. Rider, P.A. Lachenbruch, and J.B. Monroe et al. Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index Arthritis Rheum 60 2009 3425 3435
72. F. Sztajnbok, D.L. Coronel-Martinez, and A. Diaz-Maldonado et al. Discordance between physician's and parent's global assessments in juvenile idiopathic arthritis Rheumatology 46 2007 141 145
73. A. Consolaro, R. Vitale, and A. Pistorio et al. Physicians' and parents' ratings of inactive disease are frequently discordant in juvenile idiopathic arthritis J Rheumatol 34 2007 1773 1776
74. M.L. Miller, J. Ruprecht, and D. Wang et al. Physician assessment of disease activity in JIA subtypes. Analysis of data extracted from electronic medical records Pediatr Rheumatol Online J 9 2011 9
75. L.G. Rider, B.M. Feldman, and M.D. Perez et al. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group Arthritis Rheum 40 1997 1976 1983
76. G. Singh, B.H. Athreya, and J.F. Fries et al. Measurement of health status in children with juvenile rheumatoid arthritis Arthritis Rheum 37 1994 1761 1769
77. A.M. Huber, J.E. Hicks, and P.A. Lachenbruch et al. Validation of the childhood health assessment questionnaire in the juvenile idiopathic myopathies. Juvenile dermatomyositis disease activity collaborative study group J Rheumatol 28 2001 1106 1111
78. S. Meiorin, A. Pistorio, and A. Ravelli et al. Validation of the Childhood Health Assessment Questionnaire in active juvenile systemic lupus erythematosus Arthritis Rheum 59 2008 1112 1119
79. H.I. Brunner, M.S. Klein-Gitelman, and M.J. Miller et al. Minimal clinically important differences of the childhood health assessment questionnaire J Rheumatol 32 2005 150 161
80. S. Howe, J. Levinson, and E. Shear et al. Development of a disability measurement tool for juvenile rheumatoid arthritis. The Juvenile Arthritis Functional Assessment Report for Children and their Parents Arthritis Rheum 34 1991 873 880
81. G.T. Brown, F.V. Wright, and B.A. Lang et al. Clinical responsiveness of self-report functional assessment measures for children with juvenile idiopathic arthritis undergoing intraarticular corticosteroid injections Arthritis Rheum 53 2005 897 904
82. F.V. Wright, M. Law, and V. Crombie et al. Development of a self-report functional status index for juvenile rheumatoid arthritis J Rheumatol 21 1994 536 544
83. F.V. Wright, J.L. Kimber, and M. Law et al. The juvenile arthritis functional status Index (JASI): a validation study J Rheumatol 23 1996 1066 1079
84. G. Filocamo, F. Sztajnbok, and A. Cespedes-Cruz et al. Development and validation of a new short and simple measure of physical function for juvenile idiopathic arthritis Arthritis Rheum 57 2007 913 920
85. J.W. Varni, M. Seid, and T. Smith Knight et al. The PedsQL in pediatric rheumatology: reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory Generic Core Scales and Rheumatology Module Arthritis Rheum 46 2002 714 725
86. J.M. Landgraf, E. Maunsell, and K.N. Speechley et al. Canadian-French, German and UK versions of the Child Health Questionnaire: methodology and preliminary item scaling results Qual Life Res 7 1998 433 445
87. A. Hersh Measures of health-related quality of life in pediatric systemic lupus erythematosus: Childhood Health Assessment Questionnaire (C-HAQ), Child Health Questionnaire (CHQ), Pediatric Quality of Life Inventory Generic Core Module (PedsQL-GC), Pediatric Quality of Life Inventory Rheumatology Module (PedsQL-RM), and Simple Measure of Impact of Lupus Erythematosus in Youngsters (SMILEY). Arthritis Care Res (Hoboken) 63 Suppl. 11 2011 S446 S453
88. A.M. Selvaag, B. Flato, and G. Lien et al. Measuring health status in early juvenile idiopathic arthritis: determinants and responsiveness of the child health questionnaire J Rheumatol 30 2003 1602 1610
89. C.M. Duffy, L. Arsenault, and K.N. Duffy et al. The Juvenile Arthritis Quality of Life Questionnaire-development of a new responsive index for juvenile rheumatoid arthritis and juvenile spondyloarthritides J Rheumatol 24 1997 738 746
90. G. Filocamo, B. Schiappapietra, and M. Bertamino et al. A new short and simple health-related quality of life measurement for paediatric rheumatic diseases: initial validation in juvenile idiopathic arthritis Rheumatology 49 2010 1272 1280
91. P.F. Weiss, A.J. Klink, and J. Faerber et al. The pediatric rheumatology quality of life scale: validation of the English version in a US cohort of juvenile idiopathic arthritis Pediatr Rheumatol Online J 11 2013 43
92. A. Consolaro, N. Ruperto, and A. Pistorio et al. Development and initial validation of composite parent- and child-centered disease assessment indices for juvenile idiopathic arthritis Arthritis Care Res (Hoboken) 63 2011 1262 1270
93. L. Haverman, M.A. van Rossum, and M. van Veenendaal et al. Effectiveness of a web-based application to monitor health-related quality of life Pediatrics 131 2013 e533 e543
94. A. Tversky, and D. Kahneman Judgment under uncertainty: heuristics and biases Science 185 1974 1124 1131
95. A. Tversky, and D. Kahneman The framing of decisions and the psychology of choice Science 211 1981 453 458
96. J. Mateo Multi-attribute utility theory Multi Criteria Anal Renew Energy Ind Springer Lond 2012 63 72
97. B.K. Orme Getting started with conjoint analysis: strategies for product design and pricing research 2010 Research Publishers LLC
98. D. Kahneman, E. Diener, and N. Schwarz Well-being: foundations of hedonic psychology 2003 Russell Sage Foundation
99. K.C. Calman Quality of life in cancer patients-an hypothesis J Med Ethics 10 1984 124 127
100. A. Michalos Multiple discrepancies theory (MDT) Soc Indic Res 16 1985 347 413
101. G.W. Gong, M. Barrera, and J. Beyene et al. The Gap Study (GapS) interview-developing a process to determine the meaning and determinants of quality of life in children with arthritis and rheumatic disease Clin Exp Rheumatol 25 2007 486 493
102. D. Borsboom, G.J. Mellenbergh, and J. van Heerden The theoretical status of latent variables Psychol Rev 110 2003 203 219
103. H.I. Brunner, D. Maker, and B. Grundland et al. Preference-based measurement of health-related quality of life (HRQL) in children with chronic musculoskeletal disorders (MSKDs) Med Decis Making: An Int J Soc Med Decis Making 23 2003 314 322
104. L. Sung, N.L. Young, and M.L. Greenberg et al. Health-related quality of life (HRQL) scores reported from parents and their children with chronic illness differed depending on utility elicitation method J Clin Epidemiol 57 2004 1161 1166
105. E. Derman Pragmamorphism J. Brockman, This will make you smarter 2012 Doubleday